Literature DB >> 29907077

Oral Chlorhexidine Against Ventilator-Associated Pneumonia and Microbial Colonization in Intensive Care Patients.

Elem Kocaçal Güler1, Gülengün Türk2.   

Abstract

The aim of this systematic review was to determine the effect of chlorhexidine at different concentration and frequency on ventilator-associated pneumonia and microbial colonization in mechanically ventilated patients. Relevant studies in English language were identified by searching data bases between January 2010 and December 2017. Ten studies met the inclusion criteria. Chlorhexidine with 0.2% concentration was found to be more effective than the control group (placebo dental gel and normal saline) in preventing the development of ventilator-associated pneumonia in three of the eight studies. Twice-daily application was found to be effective reducing the rate of ventilator-associated pneumonia in three studies using 0.2% and 2% chlorhexidine. Microbial colonization was found to be less in 2% chlorhexidine group than herbal mouth wash 0.9% NaCl and 0.2% chlorhexidine in three studies. Chlorhexidine is an effective intervention in oral care for ventilator-associated pneumonia and microbial colonization.

Entities:  

Keywords:  chlorhexidine; intensive care unit; mechanical ventilation; microbial colonization; nursing care; oral care; ventilator-associated pneumonia

Year:  2018        PMID: 29907077     DOI: 10.1177/0193945918781531

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.967


  3 in total

1.  Risk Factors and Nursing Countermeasures of Ventilator-Associated Pneumonia in Children in the Intensive Care Unit.

Authors:  Rong Chen; Yu Liu; Xiaohong Zhang; Qin Yang; Xiao Wang
Journal:  J Healthc Eng       Date:  2022-02-17       Impact factor: 2.682

2.  Meta-Analysis of the Efficacy and Safety of Chlorhexidine for Ventilator-Associated Pneumonia Prevention in Mechanically Ventilated Patients.

Authors:  Weiying Dai; Yao Lin; Xiangying Yang; Pei Huang; Liuqin Xia; Jianping Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

Review 3.  [Update of the recommendations of the Pneumonia Zero project].

Authors:  S Arias-Rivera; R Jam-Gatell; X Nuvials-Casals; M Vázquez-Calatayud
Journal:  Enferm Intensiva       Date:  2022-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.